{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:06:15Z","timestamp":1785434775642,"version":"3.56.0"},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Current immunosuppressive treatment is used for autoimmune, inflammatory, malignant, transplant-related, and other chronic conditions that may carry elevated cerebrovascular burden. Nationally representative evidence on current immunosuppressive treatment status and self-reported lifetime stroke history remains limited. This cross-sectional study used pooled 2023\u20132024 National Health Interview Survey Adult Sample data. The analytic sample included adults aged 18 years or older with valid survey weights and complete data on exposure, outcome, and selected covariates. The exposure was current self-reported use of medications that weaken the immune system. The outcome was self-reported lifetime stroke history. Survey-weighted logistic regression estimated odds ratios and 95% confidence intervals, accounting for National Health Interview Survey stratification, clustering, and adjusted sampling weights. The final analytic sample included 60,026 adults, representing approximately 250 million United States adults. The weighted prevalence of current immunosuppressive treatment was 4.6%. Stroke history was more common among adults receiving immunosuppressive treatment than among those not receiving treatment (6.0% versus 2.8%). In unadjusted analysis, immunosuppressive treatment was associated with higher odds of stroke history (odds ratio 2.24, 95% confidence interval 1.86\u20132.70, p\u2009&lt;\u20090.001). After full adjustment for age, sex, race\/ethnicity, hypertension, diabetes, smoking status, coronary heart disease, and income-to-poverty category, the association persisted (adjusted odds ratio 1.71, 95% confidence interval 1.40\u20132.08, p\u2009&lt;\u20090.001). Current immunosuppressive treatment status, likely reflecting both medication exposure and underlying disease burden, was associated with higher odds of self-reported lifetime stroke history among United States adults. Because of the cross-sectional design, broad exposure definition, self-reported outcome, and potential confounding by indication, these findings should be interpreted as an association rather than evidence of causation.<\/jats:p>","DOI":"10.1371\/journal.pone.0355164","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:37:40Z","timestamp":1785433060000},"page":"e0355164","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current immunosuppressive treatment and self-reported lifetime stroke history among United States adults: A cross-sectional study"],"prefix":"10.1371","volume":"21","author":[{"given":"Muhammad Saad","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiza","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufaq","family":"Reyaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnoor","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4032-3989","authenticated-orcid":true,"given":"Umair Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1682-0641","authenticated-orcid":true,"given":"Baseerullah","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Talha","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"pone.0355164.ref001","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics\u20142021 update: a report from the American Heart Association","volume":"143","author":"SS Virani","year":"2021","journal-title":"Circulation"},{"issue":"6917","key":"pone.0355164.ref002","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"P Libby","year":"2002","journal-title":"Nature"},{"issue":"16","key":"pone.0355164.ref003","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"GK Hansson","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0355164.ref004","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/STROKEAHA.119.024157","article-title":"Inflammation, Autoimmunity, Infection, and Stroke: Epidemiology and Lessons From Therapeutic Intervention","volume":"51","author":"NS Parikh","year":"2020","journal-title":"Stroke"},{"issue":"21","key":"pone.0355164.ref005","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Y Shoenfeld","year":"2005","journal-title":"Circulation"},{"issue":"10354","key":"pone.0355164.ref006","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"N Conrad","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"pone.0355164.ref007","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"JA Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"pone.0355164.ref008","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/art.24537","article-title":"Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses\u2019 health study","volume":"61","author":"AE Hak","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"12","key":"pone.0355164.ref009","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.08.008","article-title":"Risk of Stroke in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"24","author":"Z Xiao","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"pone.0355164.ref010","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"H Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"12","key":"pone.0355164.ref011","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1002\/art.22255","article-title":"Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis","volume":"54","author":"DH Solomon","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"8","key":"pone.0355164.ref012","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1093\/rheumatology\/keaa862","article-title":"Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications","volume":"60","author":"MY Choi","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"pone.0355164.ref013","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jaccao.2022.11.008","article-title":"Pre-existing autoimmune disease increases the risk of cardiovascular and noncardiovascular events after immunotherapy","volume":"4","author":"C Lee","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"2","key":"pone.0355164.ref014","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00392-023-02291-4","article-title":"Cardiovascular events risk in patients with systemic autoimmune diseases: a prognostic systematic review and meta-analysis","volume":"113","author":"C Asenjo-Lobos","year":"2024","journal-title":"Clin Res Cardiol"},{"issue":"191","key":"pone.0355164.ref015","article-title":"Sample design and estimation structures for the National Health Interview Survey, 2016\u20132025","author":"C Moriarity","year":"2022","journal-title":"Vital Health Stat 2"},{"issue":"9596","key":"pone.0355164.ref016","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"E von Elm","year":"2007","journal-title":"Lancet"},{"key":"pone.0355164.ref017","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2288-10-66","article-title":"Measures and models for causal inference in cross-sectional studies: arguments for the appropriateness of the prevalence odds ratio and related logistic regression","volume":"10","author":"ME Reichenheim","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"pone.0355164.ref018","doi-asserted-by":"crossref","DOI":"10.1111\/insr.12285","article-title":"Analysis of categorical data for complex surveys","volume":"87","author":"C Skinner","year":"2019","journal-title":"Int Stat Rev"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:37:45Z","timestamp":1785433065000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355164"}},"subtitle":[],"editor":[{"given":"Marwan Salih","family":"Al-Nimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":18,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0355164","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}